What is Ningbo Menovo Pharmaceutical Co., Ltd.'s (603538.SS) StockRank?

MoatMap's StockRank for Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) is 51/100, with a Hold signal. This is a composite score combining Quality (47), Value (20), and Momentum (74) factor ranks across MoatMap's 19,000+ stock universe.

Does Ningbo Menovo Pharmaceutical Co., Ltd. have an economic moat?

Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) has a Quality factor score of 47/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Ningbo Menovo Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) is Hold, based on a StockRank of 51/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Ningbo Menovo Pharmaceutical Co., Ltd. in?

Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

603538.SS

HOLDFLAG

Ningbo Menovo Pharmaceutical Co., Ltd. · Healthcare · China · $1.6B · Avg Vol: $200M/d

StockRank

P/E (TTM)

77.9x

ROE

4.8%

D/E

0.5x

Dividend %

0.4%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Ningbo Menovo is an API and CDMO provider that stands to benefit from the secular trend of outsourced drug manufacturing. However, geopolitical tensions and legislative actions (such as the US Biosecure Act) create a highly uncertain environment for Chinese CDMOs seeking Western contracts, capping its near-term upside.

COMPANY DESCRIPTION

Ningbo Menovo Pharmaceutical is a specialized pharmaceutical company engaged in the research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and finished formulations, with a focus on cardiovascular and central nervous system therapies. The company's competitive moat lies in its advanced chemical synthesis capabilities and strict compliance with international GMP standards, enabling exports to highly regulated European and US markets. It is a prominent CDMO/API player in the global generic drug supply chain.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	215M	180M	203M	222M	1.0%
EPS	0.24	0.01	0.05	0.07	-33.2%
Shares	213M	213M	219M	221M	+3.4%
Debt	178M	192M	198M	222M	7.7%
Equity	308M	310M	324M	345M	3.9%
Op CF	41M	1M	14M	23M	-17.1%
Inv CF	7M	-48M	-15M	-15M	—
Fin CF	-26M	8M	5M	15M	—

PRICE (1M)-44.7%

SMA 50SMA 200

$5.60

RSI (14)

25.0

52W High

$10.40

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

5.3%57.7

ROE

4.8%55.8

GP/Assets

10.2%26.4

Op. Margin

13.0%71.4

FCF/Assets

-4.3%37.1

Piotroski

—83.5

Int. Cover

4.1x52.0

D/E Ratio

0.52x30.3

Current Ratio

1.45x23.4

Value

P/E (TTM)

77.9x12.7

EV/EBITDA

31.6x11.0

P/FCF

—N/A

P/B

3.6x33.0

P/S

6.0x35.7

Div Yield

0.4%11.9

Momentum

52W High %

54%28.6

RS 6M

82%96.7

SMA 50/200

1.67x98.9

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+184%86.3

Q Growth

47%74.8

FUNDAMENTALS

Market Cap

$1.6B

P/E (Forward)

27.4x

Gross Margin

31.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 603538.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
603538.SS	Ningbo Menovo Pharmaceutical Co., Ltd.(you)	$1.6B	51	HOLD
300601.SZ	Shenzhen Kangtai Biological Products Co., Ltd.	$2.1B	51	HOLD
002020.SZ	Zhejiang Jingxin Pharmaceutical Co., Ltd.	$1.7B	57	HOLD
688505.SS	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	$1.1B	52	HOLD
688131.SS	Shanghai Haoyuan Chemexpress Co., Ltd.	$2.3B	50	HOLD
600789.SS	Shandong Lukang Pharmaceutical Co.,Ltd.	$1.2B	48	HOLD
002675.SZ	Yantai Dongcheng Pharmaceutical Group Co.,Ltd.	$1.6B	43	HOLD
300026.SZ	Tianjin Chase Sun Pharmaceutical Co.,Ltd	$1.4B	43	HOLD
688799.SS	Hunan Warrant Pharmaceutical Co.,Ltd	$975M	50	HOLD
603456.SS	Zhejiang Jiuzhou Pharmaceutical Co., Ltd	$1.7B	62	HOLD

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.1%

Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) — Stock Score Summary

Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) has a MoatMap StockRank of 51/100 based on Quality (47/100), Value (20/100), and Momentum (74/100) factor scores. The current signal is HOLD. Ningbo Menovo is an API and CDMO provider that stands to benefit from the secular trend of outsourced drug manufacturing. However, geopolitical tensions and legislative actions (such as the US Biosecure Act) create a highly uncertain environment for Chinese CDMOs seeking Western contracts, capping its near-term upside.

Key Financial Metrics

Price	$5.60
Market Cap	$1.6B
P/E (TTM)	77.88
P/E (Forward)	27.42
Price/Book	3.61
Return on Equity	4.8%
Return on Invested Capital	5.3%
Debt/Equity	52.40
Gross Margin	31.6%
Operating Margin	13.0%
Revenue Growth	22.1%
Dividend Yield	0.4%
Free Cash Flow	$-5M

Ningbo Menovo Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Ningbo Menovo Pharmaceutical Co., Ltd.’s (603538.SS) StockRank?: MoatMap’s StockRank for Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) is 51/100, with a Hold signal. It is a composite of Quality (47), Value (20), and Momentum (74) factor ranks across MoatMap’s 19,000+ stock universe.
Does Ningbo Menovo Pharmaceutical Co., Ltd. have an economic moat?: Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) has a Quality factor score of 47/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Ningbo Menovo Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) is Hold, based on a StockRank of 51/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Ningbo Menovo Pharmaceutical Co., Ltd. in?: Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).